Kyle Amber to Risk Assessment
This is a "connection" page, showing publications Kyle Amber has written about Risk Assessment.
Connection Strength
0.175
-
Balancing the risks and benefits of prophylaxis: a reply to "Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions". Int J Dermatol. 2017 01; 56(1):e4-e5.
Score: 0.112
-
Patients with pemphigus are at an increased risk of developing rheumatoid arthritis: a large-scale cohort study. Immunol Res. 2020 12; 68(6):373-378.
Score: 0.037
-
An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis? Australas J Dermatol. 2016 Aug; 57(3):e114-6.
Score: 0.025